158 related articles for article (PubMed ID: 8620596)
1. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection.
Worrall NK; Chang K; Suau GM; Allison WS; Misko TP; Sullivan PM; Tilton RG; Williamson JR; Ferguson TB
Circ Res; 1996 May; 78(5):769-79. PubMed ID: 8620596
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cell-derived NO modulates cardiac allograft contractile and electrophysiological function.
Worrall NK; Pyo RT; Botney MD; Misko TP; Sullivan PM; Alexander DG; Lazenby WD; Ferguson TB
Am J Physiol; 1997 Jul; 273(1 Pt 2):H28-37. PubMed ID: 9249471
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection.
Worrall NK; Misko TP; Sullivan PM; Hui JJ; Rodi CP; Ferguson TB
Transplantation; 1996 Jan; 61(2):324-8. PubMed ID: 8600645
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection.
Worrall NK; Boasquevisque CH; Botney MD; Misko TP; Sullivan PM; Ritter JH; Ferguson TB; Patterson GA
Transplantation; 1997 Apr; 63(8):1095-101. PubMed ID: 9133470
[TBL] [Abstract][Full Text] [Related]
5. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine.
Ziolo MT; Dollinger SJ; Wahler GM
J Mol Cell Cardiol; 1998 May; 30(5):1009-17. PubMed ID: 9618241
[TBL] [Abstract][Full Text] [Related]
6. Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection.
Worrall NK; Misko TP; Botney MD; Sullivan PM; Hui JJ; Suau GM; Manning PT; Ferguson TB
Ann Thorac Surg; 1999 Mar; 67(3):716-22. PubMed ID: 10215216
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms.
Worrall NK; Chang K; LeJeune WS; Misko TP; Sullivan PM; Ferguson TB; Williamson JR
Am J Physiol; 1997 Dec; 273(6):H2565-74. PubMed ID: 9435588
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection.
Worrall NK; Boasquevisque CH; Misko TP; Sullivan PM; Ferguson TB; Patterson GA
J Heart Lung Transplant; 1997 Mar; 16(3):334-9. PubMed ID: 9087877
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection.
Shiraishi T; DeMeester SR; Worrall NK; Ritter JH; Misko TP; Ferguson TB; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1995 Nov; 110(5):1449-59; discussion 1460. PubMed ID: 7475197
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection.
Worrall NK; Misko TP; Sullivan PM; Hui JJ; Ferguson TB
Ann Thorac Surg; 1996 Aug; 62(2):378-85. PubMed ID: 8694595
[TBL] [Abstract][Full Text] [Related]
12. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition.
Soto PF; Jia CX; Rabkin DG; Hart JP; Carter YM; Sardo MJ; Hsu DT; Fisher PE; Pinsky DJ; Spotnitz HM
J Thorac Cardiovasc Surg; 2000 Jul; 120(1):39-46. PubMed ID: 10884653
[TBL] [Abstract][Full Text] [Related]
13. In situ measurement of nitric oxide production in cardiac isografts and rejecting allografts by an electrochemical method.
Joshi MS; Lancaster JR; Liu X; Ferguson TB
Nitric Oxide; 2001 Dec; 5(6):561-5. PubMed ID: 11730363
[TBL] [Abstract][Full Text] [Related]
14. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate.
Nakanishi AL; Roza AM; Adams MB; Seibel R; Moore-Hilton G; Kalyanaraman B; Pieper GM
Free Radic Biol Med; 1998 Jul; 25(2):201-7. PubMed ID: 9667497
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection.
Cai B; Roy DK; Sciacca R; Michler RE; Cannon PJ
Int J Cardiol; 1995 Jul; 50(3):243-51. PubMed ID: 8537148
[TBL] [Abstract][Full Text] [Related]
16. Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current.
Ziolo MT; Harshbarger CH; Roycroft KE; Smith JM; Romano FD; Sondgeroth KL; Wahler GM
J Mol Cell Cardiol; 2001 Sep; 33(9):1691-9. PubMed ID: 11549347
[TBL] [Abstract][Full Text] [Related]
17. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.
Worrall NK; Lazenby WD; Misko TP; Lin TS; Rodi CP; Manning PT; Tilton RG; Williamson JR; Ferguson TB
J Exp Med; 1995 Jan; 181(1):63-70. PubMed ID: 7528779
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of COX-2 during cardiac allograft rejection.
Yang X; Ma N; Szabolcs MJ; Zhong J; Athan E; Sciacca RR; Michler RE; Anderson GD; Wiese JF; Leahy KM; Gregory S; Cannon PJ
Circulation; 2000 Feb; 101(4):430-8. PubMed ID: 10653836
[TBL] [Abstract][Full Text] [Related]
19. Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction.
Skarsgard PL; Wang X; McDonald P; Lui AH; Lam EK; McManus BM; van Breemen C; Laher I
Circulation; 2000 Mar; 101(11):1303-10. PubMed ID: 10725291
[TBL] [Abstract][Full Text] [Related]
20. Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model.
Kuo PC; Alfrey EJ; Krieger NR; Abe KY; Huie P; Sibley RK; Dafoe DC
Immunology; 1996 Apr; 87(4):647-53. PubMed ID: 8675222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
